Abstract: Described embodiments provide systems and methods for performing cancer whole genome and transcriptome sequencing (cWGTS). A plurality of datasets can be generated based on sequencing of a tumor sample and a healthy control germline sample. A plurality of databases, comprising a first, second and third database, can be accessed. An RNA gene expression analysis can be performed to generate a first plurality of outputs. A DNA ploidy and allelic imbalance analysis can be performed to generate a second plurality of outputs. A variant calling analysis can be performed to generate a third plurality of outputs. A workflow may be implemented. Cohort classification scores and disease-specific classification scores for each individual level output in each of the first, second, and third pluralities of outputs can be generated. A report can be generated and provided to one or more users.

Abstract: The present disclosure is directed to managing and accessing experiment data. A data processing system may generate a system identifier for each instance that leads to a generation of experiment data. A first segment may refer to a source entity, and may be used to differentiate identifiers generated by different source entities. This implementation may aim to provide an explicit representation of the data generation process while providing a glimpse on select metadata attributes, such as an individual species, sample class, and experimental technique used to generate the dataset. These constraints may prevent duplicates and may enable system-side associations among subjects, samples, aliquots, and experiments.